Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513)

Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513)

Jiangsu Lianhuan Pharmaceutical Co., Ltd., founded in 2000, is a state-owned competitive listed company, formerly known as Yangzhou Pharmaceutical Factory, which was established in 1958. It realized A-share listing in March 2003 with the stock code of "600513".

After years of reform and development, the company has grown into a national high-tech enterprise integrating R & D, production and sales, enjoying a high reputation in the field of pharmaceutical manufacturing at home and abroad. The company's main products include urinary system drugs, antihistamines, cardiovascular drugs, steroids, antibiotics and other major series, covering chemical raw materials and injections, lyophilized preparations and solid preparations in a variety of drug dosage forms, with 135 varieties and specifications, including the national first-class new drug Epristeride, second-class new drug ebastine and felodipine core products. The company has a sound and strict quality assurance system and nationwide marketing network, and has experienced sales professionals at home and abroad. Its products have been exported to Europe, America, Southeast Asia, Australia and other more than 20 countries and regions, enjoying a good reputation in the world.

At present, the company has attracted academicians, Changjiang Scholars, many doctors and high-quality overseas returnees. It has more than 30 high-quality talents with master's degree or above and nearly 300 professional and technical personnel of all kinds.

>> tungsten carbide rings gold